TÜKliF 1535: Translational strategies for the development of innovative molecular treatment approaches in medicine
The TÜKliF (1535) takes place at the Institute for Ophthalmic Research in seminar room 2.313 each Monday from 16:00 to 17:45.
| SPEAKER | TITLE | |
|---|---|---|
| 13.10.2025 | Marius Ueffing, Martin Elmlinger | Introduction:Challenges of translation in medicinal product development. Introduction of essay topics and format |
| 20.10.2025 | Martin Elmlinger | Value chain from development to approved new medications |
| 27.10.2025 | Marius Ueffing | RD-Treat: Development program from basic research to translation |
| 03.11.2025 | Tobias Peters | Proof of concept to clinical trials: Regulatory aspects |
| 10.11.2025 | Tobias Peters | Clinical trial operations: Tasks & challenges (ICH-GCP) |
| 17.11.2025 | Francois Paquet-Durand | Qualifying a drug target (PKG) |
| 24.11.2025 | Guido Hanauer | Safety pharmacology and toxicology of candidate drugs |
| 01.12.2025 | Marius Ueffing, Martin Elmlinger | Diagnostics and biomarkers |
| 08.12.2025 | Sven Schnichels | Models for preclinical proof of concept |
| 15.12.2025 | Mathias Seeliger | Biomarkers in preclinical research |
| 12.01.2026 | Martin Elmlinger | Biomarker translation to clinical research and in precision medicine |
| 19.01.2026 | Marius Ueffing | Molecular therapy/gene therapy development |
| 26.01.2026 | Martin Elmlinger | Clinical evidence of medical devices and in-vitro diagnostics |
| 02.02.2026 | Essay discussion | |